Avaxia Biologics avaxiabiologics.com


Public lists: Pharma Startups (4732)

Avaxia is an early-stage biotechnology company focused on developing recombinant, gut-targeted antibody therapeutics for gastrointestinal diseases. These unique antibody therapeutics, called Avaximabs, are orally administered, minimally absorbed drugs that act locally in the gastrointestinal (GI) tract. Avaxia believes that treatment of GI diseases with gut-targeted antibodies has the potential to address important limitations of existing therapies.

Avaxia is an early-stage biotechnology company focused on developing recombinant, gut-targeted antibody therapeutics for gastrointestinal diseases. These unique antibody therapeutics, called Avaximabs, are orally administered, minimally absorbed drug...Show all

Company (Alive / Active)

Phone: 781-861-0062

Fax:

128 Spring Street
Suite 620
Lexington, 02421
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Avaxia Biologics $24.9M Jul 21, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Avaxia Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 21 investors
There is no Competitors data available for this company. Please select another tab.